Advanced Medical Solutions Grp PLC Directors' shareholdings (0465M)
01 May 2015 - 10:53PM
UK Regulatory
TIDMAMS
RNS Number : 0465M
Advanced Medical Solutions Grp PLC
01 May 2015
1 May 2015
Advanced Medical Solutions Group plc
("AMS" or the "Company")
Directors' shareholdings
Advanced Medical Solutions Group plc (AIM:AMS), the surgical and
advanced woundcare specialist company, was informed today that the
Trust which manages the Deferred Share Bonus Plan on behalf of the
employees of AMS has purchased ordinary shares of 5 pence each
("Ordinary Shares") on 30 April 2015, at a price of 141.5 pence per
share on behalf Chris Meredith and Mary Tavener as part of the
Deferred Share Bonus Plan and, under the terms of the Plan, these
shares will be held in trust on their behalf.
Following these transactions the beneficial ownership of Chris
Meredith and Mary Tavener is as follows:
Director Date purchased Shares Purchased Resultant Holding % of issued share capital
------------------------------------- --------------- ---------------- ----------------- -------------------------
Chris Meredith, Chief Executive
Officer 30 April 2015 2,684 1,187,891 0.6
------------------------------------- --------------- ---------------- ----------------- -------------------------
Mary Tavener, Group Finance Director 30 April 2015 1,271 1,825,698 0.9
------------------------------------- --------------- ---------------- ----------------- -------------------------
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group plc
Chris Meredith, Chief Executive Officer
Mary Tavener, Group Finance Director +44 (0) 1606 545508
----------------------------------------------------------------- ------------------------
Consilium Strategic Communications +44 (0) 20 3709 5700
Mary-Jane Elliot / Jonathan Birt / Matthew Neal / Ivar Milligan AMS@consilium-comms.com
----------------------------------------------------------------- ------------------------
Investec Bank plc (NOMAD & Broker)
Gary Clarence / Daniel Adams / Patrick Robb +44 (0) 20 7597 5970
----------------------------------------------------------------- ------------------------
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical, wound care and wound closure markets, focused on quality
outcomes for patients and value for payors. AMS has a wide range of
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it markets under its
brands ActivHeal(R) , LiquiBand(R) and RESORBA(R) as well as
supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 70 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Company has 472 employees. For more
information please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFSFEAILIIE
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2024 to May 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From May 2023 to May 2024